Great to be at the Theranostics World Congress with the Accelerate.EU consortium.
We are happy to share the progress made on Astatine-211 and targeted alpha therapies, and to highlight Antero Abrunhosa’s session today on the Accelerate.EU vision and roadmap for alpha innovation in Europe.
If you are at TWC, come and meet us. We would be glad to discuss Astatine, radiotheranostics, and how we can collectively accelerate access to these innovations for people living with cancer.
IBA RadioPharma Solutions (François-Xavier Feltz), Erasmus MC (Yann Seimbille), Forschungszentrum Jülich (B. Neumaier), Københavns Universitet – University of Copenhagen (Matthias Herth), Inserm (Jean.-Francois. Gestin), SCK CEN (Irina Primac), Universidade de Coimbra (Universidade de Coimbra) (Antero Abrunhosa) , TetraKit Technologies (Andreas Jensen), Oncidium foundation ( Rebecca Lo Bue), LabLogic Group (Katie Staunton)
hashtag#AccelerateEU hashtag#Astatine211 hashtag#Theranostics hashtag#TargetedAlphaTherapy hashtag#NuclearMedicine hashtag#IHI
